This suggests that in addition to cognitive damage, this animal model of AD also reflects the disruption of the central insulin signaling pathway, and DSS intervention may affect the expression of IRS1 and GSK3β in the central glucose metabolism pathway. This evidence concerns the gene GSK3B and Alzheimer disease.